News headlines about Validus (NYSE:VR) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Validus earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.5044015101051 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
A number of equities research analysts recently weighed in on the company. Barclays restated a “hold” rating and set a $50.00 price objective on shares of Validus in a research note on Tuesday. Zacks Investment Research restated a “strong sell” rating on shares of Validus in a research note on Saturday. Keefe, Bruyette & Woods upgraded Validus from a “market perform” rating to an “outperform” rating in a research note on Thursday, January 4th. UBS Group upped their price objective on Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a research note on Monday, October 30th. Finally, Bank of America upgraded Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $54.33.
Shares of Validus (NYSE VR) traded down $0.49 during midday trading on Tuesday, hitting $45.24. The company had a trading volume of 615,558 shares, compared to its average volume of 679,650. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52. The stock has a market cap of $3,671.14, a PE ratio of -69.60, a P/E/G ratio of 1.25 and a beta of 0.67. Validus has a 1 year low of $41.15 and a 1 year high of $58.76.
The firm also recently announced a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were given a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 3.36%. The ex-dividend date was Thursday, December 14th. Validus’s dividend payout ratio is currently -233.84%.
In related news, President Kean Driscoll sold 6,875 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $46.16, for a total transaction of $317,350.00. Following the transaction, the president now directly owns 110,858 shares of the company’s stock, valued at approximately $5,117,205.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Lixin Zeng sold 26,136 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $52.10, for a total value of $1,361,685.60. Following the transaction, the chief executive officer now directly owns 57,855 shares in the company, valued at $3,014,245.50. The disclosure for this sale can be found here. Insiders have sold a total of 39,886 shares of company stock worth $2,024,848 over the last ninety days. 2.33% of the stock is currently owned by corporate insiders.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.